Cambridge Investment Research Advisors Inc. Has $330,000 Position in Varian Medical Systems, Inc. (VAR)

Cambridge Investment Research Advisors Inc. increased its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 0.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,622 shares of the medical equipment provider’s stock after buying an additional 26 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Varian Medical Systems were worth $330,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. First Mercantile Trust Co. increased its stake in Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares in the last quarter. Heritage Trust Co acquired a new stake in Varian Medical Systems during the first quarter valued at approximately $118,000. Penserra Capital Management LLC increased its stake in Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares in the last quarter. Pacer Advisors Inc. increased its stake in Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock valued at $165,000 after buying an additional 55 shares in the last quarter. Finally, IFP Advisors Inc increased its stake in Varian Medical Systems by 8.0% in the first quarter. IFP Advisors Inc now owns 1,918 shares of the medical equipment provider’s stock valued at $175,000 after buying an additional 142 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Varian Medical Systems, Inc. (NYSE VAR) opened at 106.01 on Tuesday. The company has a 50 day moving average of $100.37 and a 200-day moving average of $88.77. The stock has a market capitalization of $9.74 billion, a P/E ratio of 34.21 and a beta of 0.62. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.08.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, April 26th. The medical equipment provider reported $0.89 EPS for the quarter, beating the consensus estimate of $0.88 by $0.01. Varian Medical Systems had a return on equity of 18.48% and a net margin of 10.58%. The company had revenue of $655 million for the quarter, compared to analysts’ expectations of $639.26 million. During the same period last year, the firm posted $1.09 earnings per share. Varian Medical Systems’s revenue was up 6.5% compared to the same quarter last year. Equities research analysts predict that Varian Medical Systems, Inc. will post $3.90 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Cambridge Investment Research Advisors Inc. Has $330,000 Position in Varian Medical Systems, Inc. (VAR)” was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/07/18/varian-medical-systems-inc-var-shares-bought-by-cambridge-investment-research-advisors-inc-updated-updated.html.

Several research firms recently commented on VAR. BidaskClub upgraded shares of Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Thursday, July 13th. Zacks Investment Research lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday, July 13th. Robert W. Baird restated a “neutral” rating and set a $99.00 price target (up previously from $89.00) on shares of Varian Medical Systems in a report on Friday. Barrington Research lowered shares of Varian Medical Systems from an “outperform” rating to a “market perform” rating in a report on Thursday, April 27th. Finally, Royal Bank Of Canada raised their price target on shares of Varian Medical Systems from $82.00 to $90.00 and gave the stock a “sector perform” rating in a report on Thursday, April 27th. Three analysts have rated the stock with a sell rating, six have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $94.21.

In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 56,573 shares of the firm’s stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $99.76, for a total value of $5,643,722.48. Following the transaction, the executive vice president now directly owns 32,737 shares of the company’s stock, valued at $3,265,843.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Susan L. Bostrom sold 3,589 shares of the firm’s stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $91.08, for a total value of $326,886.12. Following the completion of the transaction, the director now directly owns 3,809 shares in the company, valued at $346,923.72. The disclosure for this sale can be found here. Insiders have sold 147,676 shares of company stock worth $14,979,214 over the last ninety days. 0.91% of the stock is currently owned by insiders.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply